Study Comparing Conversion to Sirolimus vs. Continued Use of Calcineurin Inhibitors in Kidney Transplant Recipients
Clinical trial NCT00038948 · COMPLETED
Trial details
- NCT number
- NCT00038948
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-01-01
- Primary completion
- 2008-05-01
- Enrollment
- 830
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.